271 related articles for article (PubMed ID: 24506793)
21. Clinical expression and new SPINK5 splicing defects in Netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations.
Lacroix M; Lacaze-Buzy L; Furio L; Tron E; Valari M; Van der Wier G; Bodemer C; Bygum A; Bursztejn AC; Gaitanis G; Paradisi M; Stratigos A; Weibel L; Deraison C; Hovnanian A
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):575-82. PubMed ID: 22089833
[TBL] [Abstract][Full Text] [Related]
22. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
Komatsu N; Saijoh K; Jayakumar A; Clayman GL; Tohyama M; Suga Y; Mizuno Y; Tsukamoto K; Taniuchi K; Takehara K; Diamandis EP
J Invest Dermatol; 2008 May; 128(5):1148-59. PubMed ID: 17989726
[TBL] [Abstract][Full Text] [Related]
23. A synonymous mutation in SPINK5 exon 11 causes Netherton syndrome by altering exonic splicing regulatory elements.
Fortugno P; Grosso F; Zambruno G; Pastore S; Faletra F; Castiglia D
J Hum Genet; 2012 May; 57(5):311-5. PubMed ID: 22377713
[TBL] [Abstract][Full Text] [Related]
24. Lethal Netherton syndrome due to homozygous p.Arg371X mutation in SPINK5.
Diociaiuti A; Castiglia D; Fortugno P; Bartuli A; Pascucci M; Zambruno G; El Hachem M
Pediatr Dermatol; 2013; 30(4):e65-7. PubMed ID: 23331056
[TBL] [Abstract][Full Text] [Related]
25. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.
Fortugno P; Bresciani A; Paolini C; Pazzagli C; El Hachem M; D'Alessio M; Zambruno G
J Invest Dermatol; 2011 Nov; 131(11):2223-32. PubMed ID: 21697885
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis.
Sprecher E; Chavanas S; DiGiovanna JJ; Amin S; Nielsen K; Prendiville JS; Silverman R; Esterly NB; Spraker MK; Guelig E; de Luna ML; Williams ML; Buehler B; Siegfried EC; Van Maldergem L; Pfendner E; Bale SJ; Uitto J; Hovnanian A; Richard G
J Invest Dermatol; 2001 Aug; 117(2):179-87. PubMed ID: 11511292
[TBL] [Abstract][Full Text] [Related]
27. Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome.
Zingkou E; Pampalakis G; Sotiropoulou G
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165831. PubMed ID: 32442469
[TBL] [Abstract][Full Text] [Related]
28. Skin Biopsy in Netherton Syndrome: A Histological Review of a Large Series and New Findings.
Leclerc-Mercier S; Bodemer C; Furio L; Hadj-Rabia S; de Peufeilhoux L; Weibel L; Bursztejn AC; Bourrat E; Ortonne N; Molina TJ; Hovnanian A; Fraitag S
Am J Dermatopathol; 2016 Feb; 38(2):83-91. PubMed ID: 26825155
[TBL] [Abstract][Full Text] [Related]
29. IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome.
Hannula-Jouppi K; Laasanen SL; Heikkilä H; Tuomiranta M; Tuomi ML; Hilvo S; Kluger N; Kivirikko S; Hovnanian A; Mäkinen-Kiljunen S; Ranki A
J Allergy Clin Immunol; 2014 Oct; 134(4):985-8. PubMed ID: 25159469
[No Abstract] [Full Text] [Related]
30. When activity requires breaking up: LEKTI proteolytic activation cascade for specific proteinase inhibition.
Furio L; Hovnanian A
J Invest Dermatol; 2011 Nov; 131(11):2169-73. PubMed ID: 21997416
[TBL] [Abstract][Full Text] [Related]
31. A proinflammatory role of KLK6 protease in Netherton syndrome.
Zingkou E; Pampalakis G; Charla E; Nauroy P; Kiritsi D; Sotiropoulou G
J Dermatol Sci; 2019 Jul; 95(1):28-35. PubMed ID: 31255470
[TBL] [Abstract][Full Text] [Related]
32. Netherton Syndrome Caused by Heterozygous Frameshift Mutation Combined with Homozygous c.1258A>G Polymorphism in
Moltrasio C; Romagnuolo M; Riva D; Colavito D; Ferrucci SM; Marzano AV; Tadini G; Brena M
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239440
[TBL] [Abstract][Full Text] [Related]
33. Establishment of a mouse model of Netherton syndrome based on CRISPR/Cas9 technology.
Guo JZ; Su J; Dai H; Wang XY; Wu WB; Chen T; Zhang J; Wang WH
Eur J Dermatol; 2022 Jul; 32(4):459-463. PubMed ID: 36301754
[TBL] [Abstract][Full Text] [Related]
34. Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum.
Ng E; Hale CS; Meehan SA; Cohen DE
Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526335
[TBL] [Abstract][Full Text] [Related]
35. Netherton Syndrome: A Genotype-Phenotype Review.
Sarri CA; Roussaki-Schulze A; Vasilopoulos Y; Zafiriou E; Patsatsi A; Stamatis C; Gidarokosta P; Sotiriadis D; Sarafidou T; Mamuris Z
Mol Diagn Ther; 2017 Apr; 21(2):137-152. PubMed ID: 27905021
[TBL] [Abstract][Full Text] [Related]
36. Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial.
Di WL; Lwin SM; Petrova A; Bernadis C; Syed F; Farzaneh F; Moulding D; Martinez AE; Sebire NJ; Rampling D; Virasami A; Zamiri M; Wang W; Hara H; Kadiyirire T; Abdul-Wahab A; Martinez-Queipo M; Harper JI; McGrath JA; Thrasher AJ; Mellerio JE; Qasim W
Hum Gene Ther; 2019 Sep; 30(9):1067-1078. PubMed ID: 31288584
[TBL] [Abstract][Full Text] [Related]
37. Netherton syndrome: mutation analysis of two Taiwanese families.
Lin SP; Huang SY; Tu ME; Wu YH; Lin CY; Lin HY; Lee-Chen GJ
Arch Dermatol Res; 2007 Jun; 299(3):145-50. PubMed ID: 17415575
[TBL] [Abstract][Full Text] [Related]
38. A Novel SPINK5 Gene Mutation Associated with Netherton Syndrome in an Omani Patient.
Hamza N; Al Sukaiti N; Ahmed KAM; Romano R; Gokhale UA; Pan-Hammarström Q
Sultan Qaboos Univ Med J; 2021 Nov; 21(4):652-656. PubMed ID: 34888090
[TBL] [Abstract][Full Text] [Related]
39. Netherton's syndrome and lepromatous leprosy: a mere coincidence?
de Oliveira FL; Vasconcellos BO; de Morais TS; Nascimento MB; Teles R; da Costa Nery JA; Miranda MJ; Azulay-Abulafia L
Int J Dermatol; 2013 Feb; 52(2):186-90. PubMed ID: 23347305
[TBL] [Abstract][Full Text] [Related]
40. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome.
Descargues P; Deraison C; Prost C; Fraitag S; Mazereeuw-Hautier J; D'Alessio M; Ishida-Yamamoto A; Bodemer C; Zambruno G; Hovnanian A
J Invest Dermatol; 2006 Jul; 126(7):1622-32. PubMed ID: 16628198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
